FI41428B - - Google Patents

Info

Publication number
FI41428B
FI41428B FI0983/65A FI98365A FI41428B FI 41428 B FI41428 B FI 41428B FI 0983/65 A FI0983/65 A FI 0983/65A FI 98365 A FI98365 A FI 98365A FI 41428 B FI41428 B FI 41428B
Authority
FI
Finland
Application number
FI0983/65A
Other languages
Finnish (fi)
Other versions
FI41428C (fi
Inventor
K Herzberg
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI41428B publication Critical patent/FI41428B/fi
Application granted granted Critical
Publication of FI41428C publication Critical patent/FI41428C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI650983A 1964-04-22 1965-04-22 Influenssa-rokotteen valmistusmenetelmä FI41428C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76450A DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen

Publications (2)

Publication Number Publication Date
FI41428B true FI41428B (en:Method) 1969-07-31
FI41428C FI41428C (fi) 1969-11-10

Family

ID=6979080

Family Applications (1)

Application Number Title Priority Date Filing Date
FI650983A FI41428C (fi) 1964-04-22 1965-04-22 Influenssa-rokotteen valmistusmenetelmä

Country Status (13)

Country Link
US (1) US3422187A (en:Method)
AT (1) AT259760B (en:Method)
BE (1) BE662899A (en:Method)
BR (1) BR6569124D0 (en:Method)
CH (1) CH479700A (en:Method)
DE (1) DE1246167B (en:Method)
DK (1) DK110208C (en:Method)
FI (1) FI41428C (en:Method)
FR (1) FR1590063A (en:Method)
GB (1) GB1099555A (en:Method)
LU (1) LU48383A1 (en:Method)
NL (1) NL6505122A (en:Method)
SE (1) SE308575B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085203A (en) * 1972-04-26 1978-04-18 Burroughs Wellcome Co. Process for preparing vaccine
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US20060270248A1 (en) * 2005-05-31 2006-11-30 Gould George L Solvent Management Methods for Gel Production
US9476123B2 (en) 2005-05-31 2016-10-25 Aspen Aerogels, Inc. Solvent management methods for gel production

Also Published As

Publication number Publication date
LU48383A1 (en:Method) 1966-10-13
US3422187A (en) 1969-01-14
FI41428C (fi) 1969-11-10
NL6505122A (en:Method) 1965-10-25
GB1099555A (en) 1968-01-17
FR1590063A (en:Method) 1970-04-13
AT259760B (de) 1968-02-12
DE1246167B (de) 1967-08-03
BR6569124D0 (pt) 1973-09-20
CH479700A (de) 1969-10-15
DK110208C (da) 1970-12-21
SE308575B (en:Method) 1969-02-17
BE662899A (en:Method)

Similar Documents

Publication Publication Date Title
FR1590063A (en:Method)
AU442366B2 (en:Method)
BE642735A (en:Method)
BE642508A (en:Method)
BE659232A (en:Method)
BE642458A (en:Method)
BE642588A (en:Method)
BE47396A (en:Method)
BE642367A (en:Method)
BE658812A (en:Method)
BE657880A (en:Method)
BE642437A (en:Method)
BE637333A (en:Method)
BE632875A (en:Method)
BE659413A (en:Method)
BE483969A (en:Method)
BE642654A (en:Method)
BE647783A (en:Method)
BE642974A (en:Method)
BE628611A (en:Method)
BE610935A (en:Method)
BE659319A (en:Method)
BE658222A (en:Method)
BE564626A (en:Method)
BE642797A (en:Method)